
Computed tomography-guided radiofrequency ablation of the retained iodized oil after simultaneous combination with transarterial embolization in small recurrent or residual hepatocellular carcinoma
Author(s) -
Zijing Huang,
Yeunhwa Gu,
Shaoyong Wu,
Chun-Xiao Lai,
Xiuchen Wang,
Jinhua Huang
Publication year - 2020
Publication title -
journal of interventional medicine
Language(s) - English
Resource type - Journals
eISSN - 2096-3602
pISSN - 2590-0293
DOI - 10.1016/j.jimed.2020.01.008
Subject(s) - medicine , radiofrequency ablation , hepatocellular carcinoma , radiology , tumor progression , computed tomography , therapeutic effect , ablation , surgery , cancer
To assess the clinical efficacy and safety of transarterial embolization (TAE) in simultaneous combination with computed tomography (CT)-guided radiofrequency ablation (RFA) for recurrent or residual hepatocellular carcinoma (HCC), and to determine the risk factors influencing local tumor progression following this procedure.